Related Experiment Video
Updated: Sep 17, 2025

Experimental Protocol for Detecting Mitochondrial Function in Hepatocytes Exposed to Organochlorine Pesticides
Published on: September 16, 2020
Liraglutide attenuates clozapine-induced mitochondrial dysfunction and improves energy metabolism in the brain of
Yifang He1, Liwei Wang1, Ting Cao1
1Department of Pharmacy and Institute of Clinical Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, China; Department of Psychiatry, National Clinical Research Center for Mental Disorders, National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China; International Research Center for Precision Medicine, Transformative Technology and Software Services, Hunan, China.
Abstract:
Chronic use of antipsychotics for schizophrenia (SCZ) often causes metabolic disturbances that exacerbate cognitive impairment, and the underlying mechanisms remain unclear. As a classic antipsychotic, the metabolic toxicity of clozapine (CLZ) has been associated with the novel target progesterone receptor membrane component 1 (PGRMC1), which interacts with the glucagon-like peptide-1 receptor (GLP-1R). This study aimed to investigate the role of the GLP-1R signaling pathway in CLZ-induced metabolic toxicity and explore its potential therapeutic implications. Rats (n = 7/group) were treated with CLZ (20 mg/kg, i.p.), the GLP-1R agonist LIRA (LIRA, 0.4 mg/kg, i.p.), the GLP-1R antagonist Exendin9-39 (Ex9, 50 μg/kg, i.p.) or their combinations for three weeks, and then subjected to assess the cognitive function, neuronal activity, mitochondrial integrity and signaling pathways. The results demonstrated that CLZ impaired cognitive function and induced neuronal apoptosis, as shown by the behavioral performance and morphology staining. Electron microscopy imaging and related detections also revealed that CLZ damaged mitochondrial structure and function by decreasing TCA cycle intermediates, which resulted in reduced adenosine triphosphate (ATP) production and increased oxidative stress in both the hippocampus and prefrontal cortex. Western blotting results showed that CLZ inhibited the PGRMC1/GLP-1R/Mfn2 signaling pathway, whereas combination of LIRA treatment reversed the inhibitory changes, presenting restorative effects on CLZ-induced mitochondrial dysfunction and disturbed energy metabolism. Adversely, further addition toEx9 could abolish the protective effects of LIRA. This study highlights the importance of PGRMC1/GLP-1R/Mfn2 signaling in antipsychotic-induced neurotoxicity in mitochondria, suggesting that upregulating this pathway by GLP-1R agonist may provide a novel adjunctive therapeutic approach for SCZ.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

